Alessandro Del Conte

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Kazuhiko Nakagawa, Edward B. Garon, Takashi Seto et al. · The Lancet Oncology · 2019 · 613 citations · Full text

Medicine, Oncology, Pharmacology +12

Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial

Marco Trovò, Carlo Furlan, Jerry Polesel et al. · Radiotherapy and Oncology · 2017 · 164 citations

Medicine, Oncology, Radiation Oncology +13

First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status

Francesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri et al. · European Journal of Cancer · 2020 · 147 citations · Full text

Medicine, Oncology, Pharmacology +13

Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases

Daniele Santini, Giuseppe Perrone, Ilaria Roato et al. · Journal of Cellular Physiology · 2010 · 124 citations · Full text

Medicine, Oncology, Pathology +14

Use of nivolumab in elderly patients with advanced squamous non–small-cell lung cancer: results from the Italian cohort of an expanded access programme

Francesco Grossi, Lucio Crinò, Antonio Logroscino et al. · European Journal of Cancer · 2018 · 111 citations

Medicine, Geriatric Medicine, Oncology +13